Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations.

Maria Karlou; Angelica A Saetta; Penelope Korkolopoulou; Georgia Levidou; Pollyanthi Papanastasiou; Evmorfia Boltetsou; Dimitrios Isaiadis; Petros Pavlopoulos; Irene Thymara; Euphemia Thomas-Tsagli; Efstratios Patsouris

doi:10.1080/00313020902885011

Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations.

Maria Karlou, Angelica A Saetta, Penelope Korkolopoulou, Georgia Levidou, Pollyanthi Papanastasiou, Evmorfia Boltetsou, Dimitrios Isaiadis, Petros Pavlopoulos, Irene Thymara, Euphemia Thomas-Tsagli, Efstratios Patsouris

Institute of Pathology

Research output: Contribution to journal › Original Article › peer-review

23 Citations (Web of Science)

Original language	English
Pages (from-to)	327-334
Journal	PATHOLOGY
Volume	41
Issue number	4
DOIs	https://doi.org/10.1080/00313020902885011
Publication status	Published - 2009

Keywords

PROTEIN-KINASE
CONSTITUTIVE ACTIVATION
MALIGNANT MELANOMAS
CANCER PROGRESSION
BREAST-CANCER
MAP KINASE
BRAF GENE
EXPRESSION
PATHWAYS
MARKERS

Access to Document

10.1080/00313020902885011

Cite this

Karlou, M., Saetta, A. A., Korkolopoulou, P., Levidou, G., Papanastasiou, P., Boltetsou, E., Isaiadis, D., Pavlopoulos, P., Thymara, I., Thomas-Tsagli, E., & Patsouris, E. (2009). Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations. PATHOLOGY, 41(4), 327-334. https://doi.org/10.1080/00313020902885011

@article{ea5e44b9e5134f85a20f21cb06e080d3,

title = "Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations.",

keywords = "PROTEIN-KINASE, CONSTITUTIVE ACTIVATION, MALIGNANT MELANOMAS, CANCER PROGRESSION, BREAST-CANCER, MAP KINASE, BRAF GENE, EXPRESSION, PATHWAYS, MARKERS",

author = "Maria Karlou and Saetta, {Angelica A} and Penelope Korkolopoulou and Georgia Levidou and Pollyanthi Papanastasiou and Evmorfia Boltetsou and Dimitrios Isaiadis and Petros Pavlopoulos and Irene Thymara and Euphemia Thomas-Tsagli and Efstratios Patsouris",

year = "2009",

doi = "10.1080/00313020902885011",

language = "English",

volume = "41",

pages = "327--334",

journal = "PATHOLOGY",

issn = "0031-3025",

number = "4",

}

Karlou, M, Saetta, AA, Korkolopoulou, P, Levidou, G, Papanastasiou, P, Boltetsou, E, Isaiadis, D, Pavlopoulos, P, Thymara, I, Thomas-Tsagli, E & Patsouris, E 2009, 'Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations.', PATHOLOGY, vol. 41, no. 4, pp. 327-334. https://doi.org/10.1080/00313020902885011

TY - JOUR

T1 - Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations.

AU - Karlou, Maria

AU - Saetta, Angelica A

AU - Korkolopoulou, Penelope

AU - Levidou, Georgia

AU - Papanastasiou, Pollyanthi

AU - Boltetsou, Evmorfia

AU - Isaiadis, Dimitrios

AU - Pavlopoulos, Petros

AU - Thymara, Irene

AU - Thomas-Tsagli, Euphemia

AU - Patsouris, Efstratios

PY - 2009

Y1 - 2009

KW - PROTEIN-KINASE

KW - CONSTITUTIVE ACTIVATION

KW - MALIGNANT MELANOMAS

KW - CANCER PROGRESSION

KW - BREAST-CANCER

KW - MAP KINASE

KW - BRAF GENE

KW - EXPRESSION

KW - PATHWAYS

KW - MARKERS

U2 - 10.1080/00313020902885011

DO - 10.1080/00313020902885011

M3 - Original Article

C2 - 19404844

SN - 0031-3025

VL - 41

SP - 327

EP - 334

JO - PATHOLOGY

JF - PATHOLOGY

IS - 4

ER -